Cerebral Spinal Fluid Management Market To Reach $931.1 Million By 2030

Cerebral Spinal Fluid Management Market Growth & Trends

The global cerebral spinal fluid management market size is anticipated to reach USD 931.1 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.2% from 2024 to 2030. Constant evaluation of various techniques by neurosurgeons for improvement of hydrocephalus management is expected to drive growth in this market. Moreover, shunt manufacturers are engaged in the investment for the development of novel and improved shunts in order to tackle the pitfalls associated with the existing designs.

A significant increase in the geriatric population across the globe as well as a rise in the incidence of chronic CNS associated disorders such as stroke can be attributed to projected growth. Furthermore, grants for research in neuromodulation therapies in order to develop different products for the prognosis of various nervous system associated disorders are expected to boost development.

 Request a free sample copy or view report summary: Cerebral Spinal Fluid Management Market Report

Cerebral Spinal Fluid Management Market Report Highlights

• The CSF (Cerebral Spinal Fluid) shunts dominated the market and accounted for a share of 60.7% in 2023. This growth is attributed to the increasing use of CSF shunts for treating conditions such as hydrocephalus and the variety of devices offered by key market players.

• Adjustable valve shunts held the market and accounted for the largest market share of 64.3% in 2023 driven by technological advancements, the rising incidence of neurological conditions.

• The ventriculoatrial (VA) shunt market is expected to grow at a CAGR of 4.6% over the forecast years. The rise in minimally invasive surgical techniques drives the growth, making VA shunt implantation more accessible and less risky, further supporting market growth.

• The North America cerebral spinal fluid management market dominated the global market and accounted for the largest market share of 41.6% in 2023.

Cerebral Spinal Fluid Management Market Segmentation

Grand View Research has segmented the cerebral spinal fluid management market report based on product, valve, type, age group, and region.

Cerebral Spinal Fluid Management Product Outlook (Revenue, USD Million, 2018 - 2030)

• CSF Shunts

• CSF Drainage

Cerebral Spinal Fluid Management Valve Outlook (Revenue, USD Million, 2018 - 2030)

• Adjustable Valve Shunts

• Mono-pressure Valve Shunts

Cerebral Spinal Fluid Management Type Outlook (Revenue, USD Million, 2018 – 2030)

• Ventriculoperitoneal (VP) Shunts

• Ventriculoatrial (VA) Shunts

• Lumboperitoneal (LP) Shunts

• Ventriculopleural (VPL) Shunts

Cerebral Spinal Fluid Management Age Group Outlook (Revenue, USD Million, 2018 – 2030)

• Adult

• Pediatric

Cerebral Spinal Fluid Management Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • South Africa

  • Kuwait

List Of Key Players in the Cerebral Spinal Fluid Management Market

• B. Braun Melsungen AG.

• Integra LifeSciences Corporation.

• Medtronic.

• Spiegelberg GmbH & Co. KG.

• Sophysa

• Beckersmith Medical, Inc

• Elekta AB

• Phoenix Biomedical Corp

• Natus Medical Incorporated